Consensus CSX Corporation

Equities

CSX

US1264081035

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-17 pm EDT			5-day change	1st Jan Change
34.16 ^USD	-1.95%		-3.53%	-1.47%

12:05am	CSX beats quarterly estimates on higher intermodal, coal export volumes	RE
Apr. 17	CSX Sees Robust Export Coal Demand -- Commodity Comment	DJ

Evolution of the average Target Price on CSX Corporation

Price target over the last 5 years

History of analyst recommendation changes

f3cdc3aaf1.iXcZ0Hlnd81GuDhvBB3M4-y2pZcqRLi7yu7qDBmQBbs.6j94uiYKJ5J0wH8_Tiyfq4nQzORlLMzRmISoVFzGberDBk2AOi45gyLUWw~5bf8f6e8cacbb3a979f336c3d04eebc4

Analyst Recommendations on CSX Corporation

Bernstein Raises CSX's Price Target to $36 From $35	Apr. 15	MT
Stifel Raises Price Target on CSX to $39 From $38, Maintains Buy Rating	Apr. 12	MT
Jefferies Initiates CSX With Hold Rating, Price Target is $40	Apr. 08	MT
RBC Raises Price Target on CSX to $37 From $34, Keeps Sector Perform Rating	Apr. 01	MT
Susquehanna Raises Price Target on CSX to $44 From $42, Maintains Positive Rating	Mar. 28	MT
ANALYST RECOMMENDATIONS : Abbvie, Microsoft, Tesla, Alphabet, Booking...	Feb. 05
UBS Adjusts CSX Price Target to $40 From $37, Maintains Buy Rating	Jan. 25	MT
BMO Capital Adjusts Price Target on CSX to $38 From $37, Maintains Outperform Rating	Jan. 25	MT
Raymond James Adjusts Price Target on CSX to $38 From $35, Keeps Outperform Rating	Jan. 16	MT
Susquehanna Upgrades CSX to Positive From Neutral, Raises Price Target to $42 From $35	Jan. 08	MT
JPMorgan Trims Price Target on CSX to $39 From $40, Maintains Overweight Rating	Dec. 21	MT
Goldman Sachs Adjusts Price Target on CSX to $38 From $37, Maintains Buy Rating	23-10-20	MT
RBC Trims Price Target on CSX to $34 From $35, Keeps Sector Perform Rating	23-10-20	MT
Rose-colored glasses are back	23-10-11
JPMorgan Upgrades CSX to Overweight From Neutral, Raises Price Target to $40 From $37	23-10-11	MT
ANALYST RECOMMENDATIONS : BAE Systems, Hubspot, Intercontinental, Nasdaq, Netflix...	23-10-11
Goldman Sachs Cuts Price Target on CSX to $37 From $39, Keeps Buy Rating	23-10-10	MT
ANALYST RECOMMENDATIONS : 3M, Amgen, Eli Lilly, PepsiCo, Charles Schwabb...	23-10-09
ANALYST RECOMMENDATIONS : Biogen, Glencore, Home Depot, Meta Platforms, On Semi...	23-10-04
Barclays Adjusts CSX Price Target to $40 From $38, Maintains Overweight Rating	23-09-21	MT
BofA Securities Upgrades CSX to Buy From Neutral, Raises Price Target to $36 From $34	23-09-08	MT
ANALYST RECOMMENDATIONS : American Express, Biogen, Tesco, Eli Lilly, Oracle...	23-09-05
Goldman Sachs Adjusts Price Target on CSX to $39 From $38, Maintains Buy Rating	23-07-31	MT
RBC Downgrades CSX to Sector Perform From Outperform, Keeps Price Target at $35	23-07-31	MT
Argus Research Adjusts CSX Price Target to $37 From $35, Maintains Buy Rating	23-07-25	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

34.16 USD

Average target price

39.57 USD

Spread / Average Target

+15.82%

High Price Target

46 USD

Spread / Highest target

+34.66%

Low Price Target

30 USD

Spread / Lowest Target

-12.18%

Consensus detail

Consensus revision (last 18 months)

Analysts covering CSX Corporation

Bernstein
Stifel Nicolaus
Jefferies & Co.
RBC Capital Markets
Susquehanna
UBS
BMO Capital
Raymond James
JPMorgan Chase
Goldman Sachs
Barclays
BofA Securities
Argus
Citigroup
Benchmark Company
Morgan Stanley
TD Cowen
Stephens Inc.
Atlantic Equities
Vertical Research
Cowen
Credit Suisse
Wells Fargo Securities
Deutsche Bank Securities
Loop Capital
Benchmark Capital
Evercore ISI
TD Securities
J.P. Morgan Chase

Ratings for CSX Corporation

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar